AU2003228796A1 - Cholinesterase inhibitors to prevent injuries caused by chemicals - Google Patents

Cholinesterase inhibitors to prevent injuries caused by chemicals

Info

Publication number
AU2003228796A1
AU2003228796A1 AU2003228796A AU2003228796A AU2003228796A1 AU 2003228796 A1 AU2003228796 A1 AU 2003228796A1 AU 2003228796 A AU2003228796 A AU 2003228796A AU 2003228796 A AU2003228796 A AU 2003228796A AU 2003228796 A1 AU2003228796 A1 AU 2003228796A1
Authority
AU
Australia
Prior art keywords
chemicals
cholinesterase inhibitors
injuries caused
prevent injuries
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003228796A
Other versions
AU2003228796A8 (en
Inventor
John Ieni
Raymond Pratt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of AU2003228796A8 publication Critical patent/AU2003228796A8/en
Publication of AU2003228796A1 publication Critical patent/AU2003228796A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
AU2003228796A 2002-05-01 2003-05-01 Cholinesterase inhibitors to prevent injuries caused by chemicals Abandoned AU2003228796A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37656002P 2002-05-01 2002-05-01
US60/376,560 2002-05-01
PCT/US2003/013575 WO2003092606A2 (en) 2002-05-01 2003-05-01 Cholinesterase inhibitors to prevent injuries caused by chemicals

Publications (2)

Publication Number Publication Date
AU2003228796A8 AU2003228796A8 (en) 2003-11-17
AU2003228796A1 true AU2003228796A1 (en) 2003-11-17

Family

ID=29401361

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003228796A Abandoned AU2003228796A1 (en) 2002-05-01 2003-05-01 Cholinesterase inhibitors to prevent injuries caused by chemicals

Country Status (3)

Country Link
AU (1) AU2003228796A1 (en)
GB (1) GB2405336A (en)
WO (1) WO2003092606A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2140868A1 (en) 2000-03-03 2010-01-06 Eisai R&D Management Co., Ltd. Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments associated with or caused by chemotherapy
PT1622569E (en) 2003-04-24 2016-03-03 Incyte Corp Aza spiro alkane derivatives as inhibitors of metallproteases
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
US9132135B2 (en) * 2004-09-24 2015-09-15 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
EP2813225B1 (en) 2004-09-24 2017-12-13 University of Maryland, Baltimore Method of treating organophosphorous poisoning
AU2012200612B2 (en) * 2004-09-24 2014-11-20 The Government Of The United States, As Represented By The Secretary Of The Army Method of treating organophosphorus poisoning
JP4872044B2 (en) * 2005-09-30 2012-02-08 財団法人ヒューマンサイエンス振興財団 Cardiac remodeling inhibitor and heart failure treatment
MX2009011923A (en) 2007-05-10 2009-11-18 Amr Technology Inc Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin.
EP2642998B1 (en) 2010-11-24 2020-09-16 The Trustees of Columbia University in the City of New York A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
US9333202B2 (en) 2012-05-01 2016-05-10 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
US9938291B2 (en) 2013-03-14 2018-04-10 The Trustess Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
DK2968304T3 (en) 2013-03-14 2019-01-28 Univ Columbia 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE.
US9637450B2 (en) 2013-03-14 2017-05-02 The Trustees Of Columbia University In The City Of New York Octahydrocyclopentapyrroles, their preparation and use
US9944644B2 (en) 2013-03-14 2018-04-17 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles their preparation and use
KR102429220B1 (en) 2014-04-30 2022-08-04 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 Substituted 4-phenylpiperidines, their preparation and use
TWI698436B (en) 2014-12-30 2020-07-11 美商佛瑪治療公司 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
MA41291A (en) 2014-12-30 2017-11-07 Forma Therapeutics Inc PYRROLOTRIAZINONE AND IMIDAZOTRIAZINONE DERIVATIVES AS UBIQUE-SPECIFIC PROTEASE INHIBITORS No. 7 (USP7) FOR THE TREATMENT OF CANCER
EP3253738A1 (en) 2015-02-05 2017-12-13 Forma Therapeutics, Inc. Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
US9932351B2 (en) 2015-02-05 2018-04-03 Forma Therapeutics, Inc. Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
JP2018504432A (en) 2015-02-05 2018-02-15 フォーマ セラピューティクス，インコーポレイテッド Isothiazolopyrimidinone, pyrazolopyrimidinone and pyrrolopyrimidinone as ubiquitin-specific protease 7 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342174C1 (en) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermal therapeutic system and a method for producing a transdermal therapeutic system for the combined transdermal application of physostigmine and scopolamine for the prophylaxis and pretreatment of poisoning by highly toxic organophosphorus neurotoxins, in particular Soman and its use
DE4342173A1 (en) * 1993-12-10 1995-06-14 Lohmann Therapie Syst Lts Pharmaceutical formulation for the prophylaxis or pretreatment of poisoning by organophosphorus cholinesterase inhibitors
US6264974B1 (en) * 1998-07-07 2001-07-24 Salvagnini Italia Spa Buccal and sublingual administration of physostigmine

Also Published As

Publication number Publication date
WO2003092606A2 (en) 2003-11-13
AU2003228796A8 (en) 2003-11-17
GB0424188D0 (en) 2004-12-01
GB2405336A (en) 2005-03-02
WO2003092606A3 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
AU2003278088A1 (en) Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
AU2003228796A1 (en) Cholinesterase inhibitors to prevent injuries caused by chemicals
AU2003287136A1 (en) Novel compounds having selective inhibiting effect at gsk3
AU2003301302A1 (en) Pyradazine compounds as gsk-3 inhibitors
PL373146A1 (en) Pyridazinone-derivatives as pde4 inhibitors
AU2003299034A1 (en) Transdermal compositions
AU2003255376A1 (en) Piperidine-derivatives as pde4 inhibitors
AU2003257094A1 (en) Substituted benzimidazole compounds
AU2003258045A1 (en) Novel gamma-lactams as beta-secretase inhibitors
HK1071360A1 (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
DE60320933D1 (en) RHO-KINASE INHIBITORS
AU2003902946A0 (en) Dpp-iv inhibitor
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
AU2003207881A1 (en) Dipeptidyl peptidase inhibitors
AU2003902260A0 (en) Dpp-iv inhibitor
AU2002329877A1 (en) Cross reference to related art
AU2003902860A0 (en) Benzimidazole compounds
ZA200408423B (en) Novel tetrahydropyridine derivatives as renin inhibitors.
AU2003249531A1 (en) Azaisoquinoline derivatives as matrix metalloproteinase inhibitors
AU2003250482A1 (en) Phthalimide derivatives as matrix metalloproteinase inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
AU2003232848A1 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
AU2003277674A1 (en) Novel parp inhibitors
AU2003250469A1 (en) Isoquinoline derivatives as matrix metalloproteinase inhibitors
AU2003253176A1 (en) Monocyclic derivatives as matrix metalloproteinase inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase